

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.90701784 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.72512031 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.72512031 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 5.01430464 |
| 5 | detection of molecule of bacterial origin (GO:0032490) | 4.96050569 |
| 6 | regulation of cholesterol homeostasis (GO:2000188) | 4.94619646 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.88393003 |
| 8 | detection of other organism (GO:0098543) | 4.76870890 |
| 9 | response to peptidoglycan (GO:0032494) | 4.72364370 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.67566970 |
| 11 | cellular extravasation (GO:0045123) | 4.61303634 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.53860554 |
| 13 | detection of external biotic stimulus (GO:0098581) | 4.45580884 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40162646 |
| 15 | detection of bacterium (GO:0016045) | 4.40074931 |
| 16 | regulation of cholesterol storage (GO:0010885) | 4.39598027 |
| 17 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.39592056 |
| 18 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.39592056 |
| 19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.38467734 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.28512740 |
| 21 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.25489222 |
| 22 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.23381934 |
| 23 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.20213740 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 4.11797862 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.07245430 |
| 26 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06542094 |
| 27 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.93656230 |
| 28 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.93330440 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92956836 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.91568279 |
| 31 | positive regulation of cholesterol efflux (GO:0010875) | 3.88797428 |
| 32 | leukocyte aggregation (GO:0070486) | 3.83597270 |
| 33 | neutrophil activation (GO:0042119) | 3.81709296 |
| 34 | macrophage activation (GO:0042116) | 3.80613398 |
| 35 | microglial cell activation (GO:0001774) | 3.72113976 |
| 36 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.71603941 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.69000564 |
| 38 | response to host immune response (GO:0052572) | 3.69000564 |
| 39 | negative regulation of lipid storage (GO:0010888) | 3.67328710 |
| 40 | negative regulation of digestive system process (GO:0060457) | 3.66378129 |
| 41 | positive regulation of cholesterol transport (GO:0032376) | 3.65175705 |
| 42 | positive regulation of sterol transport (GO:0032373) | 3.65175705 |
| 43 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.64969310 |
| 44 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.59391516 |
| 45 | apoptotic cell clearance (GO:0043277) | 3.57543088 |
| 46 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.54552202 |
| 47 | response to interleukin-15 (GO:0070672) | 3.54524302 |
| 48 | granulocyte activation (GO:0036230) | 3.54023345 |
| 49 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.53938064 |
| 50 | neutrophil mediated immunity (GO:0002446) | 3.49473426 |
| 51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.47071786 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.46451638 |
| 53 | response to host (GO:0075136) | 3.46451638 |
| 54 | response to host defenses (GO:0052200) | 3.46451638 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.40542619 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.36735358 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.36735358 |
| 58 | respiratory burst (GO:0045730) | 3.36625949 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.36245840 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.36126910 |
| 61 | response to type I interferon (GO:0034340) | 3.35214970 |
| 62 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.34241375 |
| 63 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28660809 |
| 64 | * negative regulation of B cell apoptotic process (GO:0002903) | 3.27332154 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26115399 |
| 66 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.23390626 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22046200 |
| 68 | response to muramyl dipeptide (GO:0032495) | 3.21580410 |
| 69 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.19378185 |
| 70 | negative regulation of T cell mediated immunity (GO:0002710) | 3.15958884 |
| 71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.13971045 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12296665 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.07070089 |
| 74 | myeloid leukocyte mediated immunity (GO:0002444) | 3.06972850 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05873235 |
| 76 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03283101 |
| 77 | regulation of triglyceride metabolic process (GO:0090207) | 3.03121207 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 3.02271280 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.00770022 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 2.99710204 |
| 81 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.99496567 |
| 82 | defense response to protozoan (GO:0042832) | 2.99456888 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99162295 |
| 84 | triglyceride homeostasis (GO:0070328) | 2.96159780 |
| 85 | acylglycerol homeostasis (GO:0055090) | 2.96159780 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 2.95428353 |
| 87 | * germinal center formation (GO:0002467) | 2.95250787 |
| 88 | neutrophil chemotaxis (GO:0030593) | 2.93322589 |
| 89 | regulation of mast cell activation (GO:0033003) | 2.90877957 |
| 90 | regulation of tolerance induction (GO:0002643) | 2.90835672 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88305161 |
| 92 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.86423667 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.85677266 |
| 94 | neutrophil migration (GO:1990266) | 2.85391021 |
| 95 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.83258390 |
| 96 | B cell mediated immunity (GO:0019724) | 2.83142250 |
| 97 | negative regulation of interleukin-6 production (GO:0032715) | 2.82619963 |
| 98 | urea cycle (GO:0000050) | 2.81371082 |
| 99 | urea metabolic process (GO:0019627) | 2.81371082 |
| 100 | alpha-linolenic acid metabolic process (GO:0036109) | 2.80583242 |
| 101 | NLS-bearing protein import into nucleus (GO:0006607) | 2.79240516 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78818143 |
| 103 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78343779 |
| 104 | response to food (GO:0032094) | 2.77623553 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77297355 |
| 106 | * negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77206929 |
| 107 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76628782 |
| 108 | modulation by symbiont of host defense response (GO:0052031) | 2.76628782 |
| 109 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76628782 |
| 110 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76628782 |
| 111 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76628782 |
| 112 | modulation by symbiont of host immune response (GO:0052553) | 2.76628782 |
| 113 | negative regulation of innate immune response (GO:0045824) | 2.76297879 |
| 114 | positive regulation of type 2 immune response (GO:0002830) | 2.72173982 |
| 115 | regulation of interferon-alpha production (GO:0032647) | 2.71975898 |
| 116 | complement activation, alternative pathway (GO:0006957) | 2.71370900 |
| 117 | regulation of macrophage cytokine production (GO:0010935) | 2.70661803 |
| 118 | regulation of T cell tolerance induction (GO:0002664) | 2.70410704 |
| 119 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.68830945 |
| 120 | L-amino acid import (GO:0043092) | 2.68204641 |
| 121 | T-helper 1 type immune response (GO:0042088) | 2.67811694 |
| 122 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.67267652 |
| 123 | response to protozoan (GO:0001562) | 2.65958494 |
| 124 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65097753 |
| 125 | positive regulation of mast cell degranulation (GO:0043306) | 2.65097753 |
| 126 | regulation of regulated secretory pathway (GO:1903305) | 2.64258288 |
| 127 | myeloid leukocyte activation (GO:0002274) | 2.63765572 |
| 128 | * regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63720149 |
| 129 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.62787854 |
| 130 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.61147998 |
| 131 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60797350 |
| 132 | leukocyte degranulation (GO:0043299) | 2.59470872 |
| 133 | regulation of sequestering of triglyceride (GO:0010889) | 2.59459139 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58551677 |
| 135 | low-density lipoprotein particle clearance (GO:0034383) | 2.57533738 |
| 136 | T cell apoptotic process (GO:0070231) | 2.57376855 |
| 137 | regulation of cholesterol efflux (GO:0010874) | 2.54421117 |
| 138 | glutamate metabolic process (GO:0006536) | 2.53233333 |
| 139 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.52654768 |
| 140 | nitrogen cycle metabolic process (GO:0071941) | 2.51532755 |
| 141 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51500342 |
| 142 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.51334426 |
| 143 | protein carboxylation (GO:0018214) | 2.51334426 |
| 144 | C4-dicarboxylate transport (GO:0015740) | 2.49967177 |
| 145 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.48031736 |
| 146 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.46637710 |
| 147 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.40458000 |
| 148 | tryptophan catabolic process (GO:0006569) | 2.40296790 |
| 149 | indole-containing compound catabolic process (GO:0042436) | 2.40296790 |
| 150 | indolalkylamine catabolic process (GO:0046218) | 2.40296790 |
| 151 | plasma lipoprotein particle clearance (GO:0034381) | 2.40189919 |
| 152 | kynurenine metabolic process (GO:0070189) | 2.39245054 |
| 153 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.39141755 |
| 154 | carnitine metabolic process (GO:0009437) | 2.38692397 |
| 155 | regulation of lipid storage (GO:0010883) | 2.37820268 |
| 156 | cellular defense response (GO:0006968) | 2.36411590 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36082695 |
| 158 | amino-acid betaine metabolic process (GO:0006577) | 2.35168585 |
| 159 | aromatic amino acid family catabolic process (GO:0009074) | 2.34616472 |
| 160 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.34469095 |
| 161 | growth hormone receptor signaling pathway (GO:0060396) | 2.34394894 |
| 162 | negative regulation of stress fiber assembly (GO:0051497) | 2.33995661 |
| 163 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.33724762 |
| 164 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.33235580 |
| 165 | L-phenylalanine catabolic process (GO:0006559) | 2.33235580 |
| 166 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.32880195 |
| 167 | regulation of protein activation cascade (GO:2000257) | 2.32311838 |
| 168 | * regulation of B cell apoptotic process (GO:0002902) | 2.31520710 |
| 169 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.31496599 |
| 170 | tryptophan metabolic process (GO:0006568) | 2.30947615 |
| 171 | membrane tubulation (GO:0097320) | 2.30755922 |
| 172 | cytidine deamination (GO:0009972) | 2.30728913 |
| 173 | cytidine metabolic process (GO:0046087) | 2.30728913 |
| 174 | cytidine catabolic process (GO:0006216) | 2.30728913 |
| 175 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.30368791 |
| 176 | response to fungus (GO:0009620) | 2.30112018 |
| 177 | bile acid biosynthetic process (GO:0006699) | 2.29672449 |
| 178 | phospholipid homeostasis (GO:0055091) | 2.29375633 |
| 179 | desmosome organization (GO:0002934) | 2.28480120 |
| 180 | negative regulation of lipid transport (GO:0032369) | 2.26507544 |
| 181 | regulation of complement activation (GO:0030449) | 2.25884604 |
| 182 | I-kappaB phosphorylation (GO:0007252) | 2.25082246 |
| 183 | positive regulation of p38MAPK cascade (GO:1900745) | 2.24890761 |
| 184 | cytokine biosynthetic process (GO:0042089) | 2.22899022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79662074 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.62639263 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.98141020 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84571694 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79465964 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48989739 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.45125245 |
| 8 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35335273 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.35300818 |
| 10 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27782020 |
| 11 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.21569413 |
| 12 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09151732 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07662381 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06809901 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01887195 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99400120 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96942316 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91451669 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.90440775 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89766944 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88654340 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88414120 |
| 23 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87799506 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83302909 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82988317 |
| 26 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77517447 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77210631 |
| 28 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73148480 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70545319 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68466019 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64454572 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60916574 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56725143 |
| 34 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55759209 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54017898 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.50773905 |
| 37 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50710845 |
| 38 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.50032829 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43425610 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43357602 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38950039 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38400746 |
| 43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.38154828 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37658687 |
| 45 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37209356 |
| 46 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33885415 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.32284624 |
| 48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31737244 |
| 49 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31465434 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30583557 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29580110 |
| 52 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25495929 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24940526 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22794263 |
| 55 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21044918 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19979057 |
| 57 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17414253 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16595102 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16504368 |
| 60 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16328562 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16276619 |
| 62 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15030266 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14656592 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14611712 |
| 65 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14273169 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13930613 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13539399 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.13437470 |
| 69 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12878947 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12828304 |
| 71 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12589638 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12245447 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12015047 |
| 74 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11412522 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11367711 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10962780 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10066891 |
| 78 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09055973 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07813722 |
| 80 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07686138 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07420796 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06232843 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06081208 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05523489 |
| 85 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05486026 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04275700 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03916329 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03858488 |
| 89 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03705336 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02504909 |
| 91 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.02147817 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01431833 |
| 93 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01283590 |
| 94 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00628902 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00490122 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00346328 |
| 97 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99831013 |
| 98 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99831013 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99589217 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99374621 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96977843 |
| 102 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.95866456 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.95626987 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95145893 |
| 105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94829200 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94781702 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94770647 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94402595 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93936571 |
| 110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93616523 |
| 111 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93255191 |
| 112 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93105950 |
| 113 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93105950 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92847003 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92088293 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92083495 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91140949 |
| 118 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91076502 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90964437 |
| 120 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.90338803 |
| 121 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88948121 |
| 122 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.87190220 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86936419 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86384602 |
| 125 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86372718 |
| 126 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85926068 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85565981 |
| 128 | * MYB_26560356_Chip-Seq_TH2_Human | 0.85481560 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84200289 |
| 130 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84184366 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84070173 |
| 132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83785464 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83699874 |
| 134 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83167168 |
| 135 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81885006 |
| 136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81436282 |
| 137 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.81012865 |
| 138 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.80368627 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78979780 |
| 140 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.78274374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.78660784 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.59989084 |
| 3 | MP0005365_abnormal_bile_salt | 3.60591393 |
| 4 | MP0005360_urolithiasis | 2.82792472 |
| 5 | MP0003329_amyloid_beta_deposits | 2.40309328 |
| 6 | MP0000604_amyloidosis | 2.34071340 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.09342441 |
| 8 | MP0003303_peritoneal_inflammation | 2.06154864 |
| 9 | MP0004130_abnormal_muscle_cell | 2.03657811 |
| 10 | MP0003436_decreased_susceptibility_to | 2.02241993 |
| 11 | MP0010329_abnormal_lipoprotein_level | 1.98922399 |
| 12 | MP0003828_pulmonary_edema | 1.98106028 |
| 13 | MP0008260_abnormal_autophagy | 1.97044523 |
| 14 | MP0004510_myositis | 1.95049114 |
| 15 | MP0003724_increased_susceptibility_to | 1.94322854 |
| 16 | * MP0005387_immune_system_phenotype | 1.93572403 |
| 17 | * MP0001790_abnormal_immune_system | 1.93572403 |
| 18 | MP0009278_abnormal_bone_marrow | 1.87318646 |
| 19 | MP0002132_abnormal_respiratory_system | 1.86590791 |
| 20 | MP0003252_abnormal_bile_duct | 1.85453478 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.82159895 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.76137869 |
| 23 | * MP0001800_abnormal_humoral_immune | 1.70444064 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.65153826 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.63531154 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.63516426 |
| 27 | MP0002254_reproductive_system_inflammat | 1.62560589 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.61261891 |
| 29 | MP0009785_altered_susceptibility_to | 1.57573862 |
| 30 | MP0003646_muscle_fatigue | 1.55440371 |
| 31 | MP0004883_abnormal_blood_vessel | 1.50389345 |
| 32 | MP0002419_abnormal_innate_immunity | 1.49910238 |
| 33 | MP0005025_abnormal_response_to | 1.46884720 |
| 34 | MP0009840_abnormal_foam_cell | 1.45149616 |
| 35 | * MP0002398_abnormal_bone_marrow | 1.44013692 |
| 36 | MP0005164_abnormal_response_to | 1.42620592 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.42353249 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.42003527 |
| 39 | MP0004381_abnormal_hair_follicle | 1.39763733 |
| 40 | MP0005670_abnormal_white_adipose | 1.38655813 |
| 41 | MP0003075_altered_response_to | 1.36662047 |
| 42 | * MP0000685_abnormal_immune_system | 1.36615183 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.35939637 |
| 44 | MP0005671_abnormal_response_to | 1.34619607 |
| 45 | * MP0000609_abnormal_liver_physiology | 1.33909388 |
| 46 | * MP0002452_abnormal_antigen_presenting | 1.31800204 |
| 47 | MP0008004_abnormal_stomach_pH | 1.31447656 |
| 48 | * MP0002723_abnormal_immune_serum | 1.30919698 |
| 49 | MP0004947_skin_inflammation | 1.30842615 |
| 50 | MP0005083_abnormal_biliary_tract | 1.29760381 |
| 51 | MP0006082_CNS_inflammation | 1.26781172 |
| 52 | * MP0008469_abnormal_protein_level | 1.26115434 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.25228107 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.25228107 |
| 55 | MP0000858_altered_metastatic_potential | 1.24505769 |
| 56 | MP0003195_calcinosis | 1.24147385 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.23858344 |
| 58 | MP0005332_abnormal_amino_acid | 1.22996173 |
| 59 | MP0000751_myopathy | 1.22819268 |
| 60 | MP0009764_decreased_sensitivity_to | 1.21768935 |
| 61 | MP0003866_abnormal_defecation | 1.20587780 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.19537680 |
| 63 | MP0005647_abnormal_sex_gland | 1.19010051 |
| 64 | MP0000747_muscle_weakness | 1.18460207 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.17395257 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.16784685 |
| 67 | * MP0002722_abnormal_immune_system | 1.16522644 |
| 68 | MP0005310_abnormal_salivary_gland | 1.16453524 |
| 69 | MP0002971_abnormal_brown_adipose | 1.16443849 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.15304642 |
| 71 | MP0002429_abnormal_blood_cell | 1.13449038 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11091816 |
| 73 | MP0003690_abnormal_glial_cell | 1.10255661 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.09701972 |
| 75 | MP0005666_abnormal_adipose_tissue | 1.09596431 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.08207684 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.07856516 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.05896748 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.03733555 |
| 80 | * MP0002420_abnormal_adaptive_immunity | 1.03494214 |
| 81 | MP0002933_joint_inflammation | 1.03475495 |
| 82 | * MP0001819_abnormal_immune_cell | 1.03471110 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.02332644 |
| 84 | MP0005451_abnormal_body_composition | 1.02042048 |
| 85 | * MP0001853_heart_inflammation | 1.00984497 |
| 86 | MP0003045_fibrosis | 1.00877261 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.99351946 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.98129594 |
| 89 | * MP0001845_abnormal_inflammatory_respons | 0.97520670 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.96999243 |
| 91 | MP0005390_skeleton_phenotype | 0.94958086 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.93705817 |
| 93 | MP0002396_abnormal_hematopoietic_system | 0.93680592 |
| 94 | MP0003448_altered_tumor_morphology | 0.93496828 |
| 95 | MP0003091_abnormal_cell_migration | 0.91586648 |
| 96 | MP0000749_muscle_degeneration | 0.91032827 |
| 97 | MP0000343_altered_response_to | 0.90441816 |
| 98 | * MP0000703_abnormal_thymus_morphology | 0.89488079 |
| 99 | MP0009763_increased_sensitivity_to | 0.88691648 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.86266976 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.85139929 |
| 102 | MP0005464_abnormal_platelet_physiology | 0.84653054 |
| 103 | * MP0004087_abnormal_muscle_fiber | 0.83976486 |
| 104 | MP0001958_emphysema | 0.83444944 |
| 105 | MP0005166_decreased_susceptibility_to | 0.81953872 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.81463562 |
| 107 | MP0003806_abnormal_nucleotide_metabolis | 0.80690897 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.80324288 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.79990972 |
| 110 | MP0004484_altered_response_of | 0.79400937 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.78615541 |
| 112 | MP0005535_abnormal_body_temperature | 0.77734415 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.76276401 |
| 114 | MP0000383_abnormal_hair_follicle | 0.75912234 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.75776894 |
| 116 | MP0000920_abnormal_myelination | 0.72639365 |
| 117 | MP0010155_abnormal_intestine_physiology | 0.71694014 |
| 118 | MP0000716_abnormal_immune_system | 0.71178415 |
| 119 | MP0002006_tumorigenesis | 0.71167706 |
| 120 | MP0000249_abnormal_blood_vessel | 0.70259793 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.69624599 |
| 122 | MP0002106_abnormal_muscle_physiology | 0.69221561 |
| 123 | MP0002060_abnormal_skin_morphology | 0.68531594 |
| 124 | MP0008874_decreased_physiological_sensi | 0.68355249 |
| 125 | MP0003795_abnormal_bone_structure | 0.68059305 |
| 126 | MP0003279_aneurysm | 0.66346480 |
| 127 | MP0004858_abnormal_nervous_system | 0.65104073 |
| 128 | MP0001851_eye_inflammation | 0.64970261 |
| 129 | MP0002133_abnormal_respiratory_system | 0.64904897 |
| 130 | MP0005388_respiratory_system_phenotype | 0.64904897 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64866001 |
| 132 | * MP0002405_respiratory_system_inflammati | 0.64528566 |
| 133 | * MP0000689_abnormal_spleen_morphology | 0.63485730 |
| 134 | MP0001663_abnormal_digestive_system | 0.63471959 |
| 135 | MP0005275_abnormal_skin_tensile | 0.62674656 |
| 136 | MP0009765_abnormal_xenobiotic_induced | 0.62671313 |
| 137 | MP0009115_abnormal_fat_cell | 0.62310041 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.61937160 |
| 139 | MP0002796_impaired_skin_barrier | 0.61432108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 5.23813019 |
| 2 | Optic neuritis (HP:0100653) | 5.23813019 |
| 3 | Complement deficiency (HP:0004431) | 4.21788255 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.94265645 |
| 5 | Keratoconjunctivitis sicca (HP:0001097) | 3.87840307 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.70261272 |
| 7 | Hemiplegia (HP:0002301) | 3.65961058 |
| 8 | Increased IgE level (HP:0003212) | 3.57394747 |
| 9 | Keratoconjunctivitis (HP:0001096) | 3.53635645 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.48762036 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.45039191 |
| 12 | Abnormality of complement system (HP:0005339) | 3.42866486 |
| 13 | Myocardial infarction (HP:0001658) | 3.27115132 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.22443733 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.18495106 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.16491446 |
| 17 | Encephalitis (HP:0002383) | 3.13755406 |
| 18 | Xanthomatosis (HP:0000991) | 3.09702942 |
| 19 | Parakeratosis (HP:0001036) | 3.08380679 |
| 20 | Peritonitis (HP:0002586) | 3.05443332 |
| 21 | Fatigable weakness (HP:0003473) | 3.03280981 |
| 22 | Abnormality of the neuromuscular junction (HP:0003398) | 3.03280981 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98033447 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98033447 |
| 25 | Chest pain (HP:0100749) | 2.94416093 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.92975516 |
| 27 | Urticaria (HP:0001025) | 2.92851131 |
| 28 | Hemoptysis (HP:0002105) | 2.91717792 |
| 29 | Episodic fever (HP:0001954) | 2.89849689 |
| 30 | Arterial thrombosis (HP:0004420) | 2.82923734 |
| 31 | Abnormality of the parathyroid morphology (HP:0011766) | 2.80578045 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.79309653 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.74894232 |
| 34 | Gingivitis (HP:0000230) | 2.74826596 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 2.73770367 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.72388912 |
| 37 | Muscle fiber splitting (HP:0003555) | 2.69879596 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.69704200 |
| 39 | Abnormality of placental membranes (HP:0011409) | 2.64633143 |
| 40 | Amniotic constriction ring (HP:0009775) | 2.64633143 |
| 41 | Pulmonary embolism (HP:0002204) | 2.63899527 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.63821780 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.58840967 |
| 44 | Amyloidosis (HP:0011034) | 2.58726798 |
| 45 | Glomerulonephritis (HP:0000099) | 2.58637250 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.53076197 |
| 47 | Joint hemorrhage (HP:0005261) | 2.51447967 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.51403526 |
| 49 | Hypochromic anemia (HP:0001931) | 2.50411866 |
| 50 | Gangrene (HP:0100758) | 2.44504257 |
| 51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.43774608 |
| 52 | Anorexia (HP:0002039) | 2.42894287 |
| 53 | Abnormality of the endocardium (HP:0004306) | 2.41174778 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.40686699 |
| 55 | Humeroradial synostosis (HP:0003041) | 2.39119041 |
| 56 | Synostosis involving the elbow (HP:0003938) | 2.39119041 |
| 57 | Nephritis (HP:0000123) | 2.37083400 |
| 58 | Epistaxis (HP:0000421) | 2.33565035 |
| 59 | Leukocytosis (HP:0001974) | 2.32266478 |
| 60 | Stomatitis (HP:0010280) | 2.31850128 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.31261916 |
| 62 | Osteomyelitis (HP:0002754) | 2.29876036 |
| 63 | Hyperglycinuria (HP:0003108) | 2.27870369 |
| 64 | T lymphocytopenia (HP:0005403) | 2.26952113 |
| 65 | Intrahepatic cholestasis (HP:0001406) | 2.26947670 |
| 66 | Mitral stenosis (HP:0001718) | 2.23743793 |
| 67 | Severe combined immunodeficiency (HP:0004430) | 2.21783537 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.21409064 |
| 69 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.20665441 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.20170108 |
| 71 | Nasal polyposis (HP:0100582) | 2.19789463 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.18208233 |
| 73 | Vertigo (HP:0002321) | 2.16403483 |
| 74 | Weak cry (HP:0001612) | 2.15055198 |
| 75 | Hyporeflexia of lower limbs (HP:0002600) | 2.14501256 |
| 76 | Renal cell carcinoma (HP:0005584) | 2.14248068 |
| 77 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12885494 |
| 78 | Hypoalphalipoproteinemia (HP:0003233) | 2.11936416 |
| 79 | * Mediastinal lymphadenopathy (HP:0100721) | 2.10140087 |
| 80 | Colitis (HP:0002583) | 2.07932857 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.07846906 |
| 82 | Epidermoid cyst (HP:0200040) | 2.07771059 |
| 83 | Type 2 muscle fiber atrophy (HP:0003554) | 2.05242692 |
| 84 | Obstructive lung disease (HP:0006536) | 2.05108072 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05108072 |
| 86 | Acne (HP:0001061) | 2.04308908 |
| 87 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.03615102 |
| 88 | Purpura (HP:0000979) | 2.03283555 |
| 89 | Recurrent fungal infections (HP:0002841) | 2.02787886 |
| 90 | Pustule (HP:0200039) | 2.02764430 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.01715164 |
| 92 | Hemiparesis (HP:0001269) | 2.01604627 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.00966573 |
| 94 | Sepsis (HP:0100806) | 2.00803724 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 2.00197741 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99622143 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99622143 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99622143 |
| 99 | Thick nail (HP:0001805) | 1.99039346 |
| 100 | Chronic otitis media (HP:0000389) | 1.98767923 |
| 101 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98748981 |
| 102 | Ketosis (HP:0001946) | 1.98574537 |
| 103 | * Abnormality of the pleura (HP:0002103) | 1.98314706 |
| 104 | Loss of speech (HP:0002371) | 1.97496160 |
| 105 | Exercise-induced muscle cramps (HP:0003710) | 1.97132009 |
| 106 | Axonal loss (HP:0003447) | 1.96497996 |
| 107 | Hyperammonemia (HP:0001987) | 1.95580340 |
| 108 | Polycythemia (HP:0001901) | 1.95128427 |
| 109 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94948199 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 1.94508176 |
| 111 | Abnormality of macrophages (HP:0004311) | 1.94437925 |
| 112 | Gastrointestinal stroma tumor (HP:0100723) | 1.94306513 |
| 113 | Combined immunodeficiency (HP:0005387) | 1.94072445 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 1.93575125 |
| 115 | Increased connective tissue (HP:0009025) | 1.92985031 |
| 116 | Vasculitis (HP:0002633) | 1.92970234 |
| 117 | Glomerulopathy (HP:0100820) | 1.91994919 |
| 118 | Increased serum ferritin (HP:0003281) | 1.91263959 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.90506023 |
| 120 | Hydroxyprolinuria (HP:0003080) | 1.90506023 |
| 121 | Joint swelling (HP:0001386) | 1.88225901 |
| 122 | Microcytic anemia (HP:0001935) | 1.86363809 |
| 123 | Hypercholesterolemia (HP:0003124) | 1.86048728 |
| 124 | Lower limb amyotrophy (HP:0007210) | 1.85458353 |
| 125 | Recurrent bronchitis (HP:0002837) | 1.85367048 |
| 126 | Muscle fiber inclusion bodies (HP:0100299) | 1.84825523 |
| 127 | Recurrent skin infections (HP:0001581) | 1.84391670 |
| 128 | Granulocytopenia (HP:0001913) | 1.83948307 |
| 129 | Keratitis (HP:0000491) | 1.83398326 |
| 130 | Nonprogressive disorder (HP:0003680) | 1.83184252 |
| 131 | Abnormality of the pericardium (HP:0001697) | 1.83114587 |
| 132 | Dysostosis multiplex (HP:0000943) | 1.83017695 |
| 133 | Muscle fiber atrophy (HP:0100295) | 1.82964812 |
| 134 | * Meningitis (HP:0001287) | 1.82778509 |
| 135 | Polyneuropathy (HP:0001271) | 1.82038109 |
| 136 | Metaphyseal cupping (HP:0003021) | 1.81731528 |
| 137 | Broad metatarsal (HP:0001783) | 1.81622025 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 1.80968242 |
| 139 | Pancreatitis (HP:0001733) | 1.80967458 |
| 140 | Gingival bleeding (HP:0000225) | 1.79811586 |
| 141 | Increased cerebral lipofuscin (HP:0011813) | 1.79766688 |
| 142 | Increased IgM level (HP:0003496) | 1.79661047 |
| 143 | Upper limb muscle weakness (HP:0003484) | 1.79384567 |
| 144 | Vascular calcification (HP:0004934) | 1.79266050 |
| 145 | Increased CSF protein (HP:0002922) | 1.79239606 |
| 146 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78316276 |
| 147 | Skin ulcer (HP:0200042) | 1.78181521 |
| 148 | Obstructive sleep apnea (HP:0002870) | 1.77888275 |
| 149 | Esophageal varix (HP:0002040) | 1.77793639 |
| 150 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77455835 |
| 151 | Ketoacidosis (HP:0001993) | 1.76942973 |
| 152 | Atrophic scars (HP:0001075) | 1.76915156 |
| 153 | Difficulty running (HP:0009046) | 1.76798641 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.76680358 |
| 155 | Abnormality of T cells (HP:0002843) | 1.76344847 |
| 156 | Orchitis (HP:0100796) | 1.75754028 |
| 157 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75415029 |
| 158 | Cellulitis (HP:0100658) | 1.74487638 |
| 159 | Cardiovascular calcification (HP:0011915) | 1.73723820 |
| 160 | Subacute progressive viral hepatitis (HP:0006572) | 1.73696561 |
| 161 | Abnormality of binocular vision (HP:0011514) | 1.73610497 |
| 162 | Diplopia (HP:0000651) | 1.73610497 |
| 163 | Status epilepticus (HP:0002133) | 1.72184424 |
| 164 | Round ear (HP:0100830) | 1.71617614 |
| 165 | Myositis (HP:0100614) | 1.70809161 |
| 166 | Interstitial pulmonary disease (HP:0006530) | 1.70752847 |
| 167 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70178065 |
| 168 | Recurrent viral infections (HP:0004429) | 1.70124279 |
| 169 | Abnormality of T cell physiology (HP:0011840) | 1.69623829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 4.56127905 |
| 2 | MAP3K13 | 3.09256738 |
| 3 | ERN1 | 2.75361184 |
| 4 | MAP3K14 | 2.55895180 |
| 5 | GRK1 | 2.47876648 |
| 6 | MAP3K9 | 2.45930096 |
| 7 | MAP4K1 | 2.39734860 |
| 8 | RIPK4 | 2.31708651 |
| 9 | IKBKB | 2.15613934 |
| 10 | TRIB3 | 2.07099956 |
| 11 | TYK2 | 2.06990856 |
| 12 | PRPF4B | 2.02275602 |
| 13 | TNK2 | 2.00662444 |
| 14 | MAP3K7 | 1.83549840 |
| 15 | SIK1 | 1.82729103 |
| 16 | FGFR4 | 1.77445802 |
| 17 | JAK1 | 1.74674482 |
| 18 | TTN | 1.67110503 |
| 19 | TAOK3 | 1.60075956 |
| 20 | PTK6 | 1.58022651 |
| 21 | TBK1 | 1.57614108 |
| 22 | KSR2 | 1.53565244 |
| 23 | EPHB1 | 1.52211727 |
| 24 | NTRK3 | 1.50068205 |
| 25 | BLK | 1.48446040 |
| 26 | MAP3K11 | 1.42048868 |
| 27 | RIPK1 | 1.39742514 |
| 28 | PRKCH | 1.24336919 |
| 29 | IRAK3 | 1.22503704 |
| 30 | TGFBR2 | 1.19316587 |
| 31 | TAOK1 | 1.17091261 |
| 32 | MAP3K6 | 1.15199596 |
| 33 | IRAK4 | 1.13936862 |
| 34 | KIT | 1.13000099 |
| 35 | IKBKE | 1.11269390 |
| 36 | JAK3 | 1.08761117 |
| 37 | FGFR3 | 1.08725379 |
| 38 | TXK | 1.07235373 |
| 39 | PIK3CG | 1.06414384 |
| 40 | CSK | 1.05161401 |
| 41 | MAP2K3 | 1.04831975 |
| 42 | OBSCN | 1.02122721 |
| 43 | IRAK2 | 1.02017258 |
| 44 | MAP3K2 | 1.01994071 |
| 45 | CAMK1D | 1.00830094 |
| 46 | SGK3 | 1.00323045 |
| 47 | IRAK1 | 0.95371433 |
| 48 | SIK3 | 0.94152348 |
| 49 | CDC42BPA | 0.94038464 |
| 50 | JAK2 | 0.92829027 |
| 51 | YES1 | 0.92798660 |
| 52 | PIK3CA | 0.92075079 |
| 53 | PRKAA2 | 0.90630408 |
| 54 | HCK | 0.90401564 |
| 55 | PRKCQ | 0.90284895 |
| 56 | CAMK1G | 0.90079542 |
| 57 | CSF1R | 0.89941520 |
| 58 | MAP3K3 | 0.88749909 |
| 59 | MAP3K1 | 0.86805317 |
| 60 | BMX | 0.86764745 |
| 61 | MAPK7 | 0.86163748 |
| 62 | DMPK | 0.85354310 |
| 63 | MST1R | 0.84597094 |
| 64 | SYK | 0.84195851 |
| 65 | CHUK | 0.83035993 |
| 66 | PKN2 | 0.81308397 |
| 67 | MARK3 | 0.80969143 |
| 68 | MATK | 0.78095730 |
| 69 | MAPK12 | 0.78001488 |
| 70 | DAPK2 | 0.75519520 |
| 71 | PHKG2 | 0.75083875 |
| 72 | PHKG1 | 0.75083875 |
| 73 | BTK | 0.74785503 |
| 74 | EPHA3 | 0.74648028 |
| 75 | SGK2 | 0.74193182 |
| 76 | BMPR2 | 0.73588765 |
| 77 | SGK1 | 0.71836473 |
| 78 | ITK | 0.70408823 |
| 79 | MAP2K4 | 0.69386942 |
| 80 | MAPK15 | 0.66655264 |
| 81 | SIK2 | 0.66298744 |
| 82 | BCKDK | 0.64915147 |
| 83 | PRKD2 | 0.62450971 |
| 84 | PTK2B | 0.62380526 |
| 85 | WNK1 | 0.60654101 |
| 86 | DYRK1B | 0.60501754 |
| 87 | MST4 | 0.60232663 |
| 88 | SMG1 | 0.60190141 |
| 89 | GRK6 | 0.59650468 |
| 90 | HIPK2 | 0.59516597 |
| 91 | ZAP70 | 0.58630791 |
| 92 | PRKD1 | 0.58003747 |
| 93 | MAP2K6 | 0.57810138 |
| 94 | FES | 0.56526586 |
| 95 | LRRK2 | 0.55963555 |
| 96 | STK11 | 0.55384821 |
| 97 | LCK | 0.54601443 |
| 98 | GRK7 | 0.53551800 |
| 99 | CAMK4 | 0.52894942 |
| 100 | MOS | 0.52871569 |
| 101 | FGR | 0.52405229 |
| 102 | FYN | 0.52151385 |
| 103 | CAMKK1 | 0.51654639 |
| 104 | NEK9 | 0.51531116 |
| 105 | STK38 | 0.51247340 |
| 106 | STK10 | 0.50970661 |
| 107 | INSRR | 0.50083444 |
| 108 | PDK1 | 0.48474359 |
| 109 | NLK | 0.48210821 |
| 110 | KSR1 | 0.48100449 |
| 111 | MAPK11 | 0.48040023 |
| 112 | TEC | 0.46971789 |
| 113 | ROCK1 | 0.45884963 |
| 114 | RAF1 | 0.45690756 |
| 115 | PDGFRB | 0.45585520 |
| 116 | TNIK | 0.45201508 |
| 117 | PDPK1 | 0.44947376 |
| 118 | CAMKK2 | 0.44623842 |
| 119 | IGF1R | 0.44034422 |
| 120 | RET | 0.43541601 |
| 121 | SGK494 | 0.43468962 |
| 122 | SGK223 | 0.43468962 |
| 123 | RPS6KL1 | 0.42904410 |
| 124 | RPS6KC1 | 0.42904410 |
| 125 | TAOK2 | 0.42710912 |
| 126 | CDK6 | 0.41455709 |
| 127 | MARK2 | 0.40723897 |
| 128 | MAP3K10 | 0.39507464 |
| 129 | LYN | 0.39349404 |
| 130 | PRKCE | 0.38838797 |
| 131 | MAPKAPK2 | 0.38373480 |
| 132 | MAP3K5 | 0.38110113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49016884 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74332085 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58171918 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37741517 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03015935 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.98361962 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96460370 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87894119 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85297066 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77286952 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.71785602 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58983343 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.56137055 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53323964 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50880384 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49155158 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45261864 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.41732178 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41727934 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40772413 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40486824 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28707851 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27032095 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.24969099 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.21824370 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21477895 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20295802 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20245195 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17611921 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16841539 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.15756347 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12972968 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12469481 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.11337563 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10263467 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.09534686 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08773241 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08693103 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.07854623 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02246268 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01964910 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01930611 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01110324 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.98949214 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96444483 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94813679 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93002312 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.91774108 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.91257421 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90168376 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89933906 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89367982 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88696875 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88580117 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88109472 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87218830 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87109666 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83944211 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82024701 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81774629 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81762549 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81204343 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80789338 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.77607810 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75742584 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74765629 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74439918 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.74309803 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.73621525 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73555419 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.73253445 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72781753 |
| 73 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72132006 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.71886286 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.70507422 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70379648 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69598468 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68059645 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68057489 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67251192 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66985381 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66746884 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66248241 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65877212 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64820179 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.64726497 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.63871446 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63264457 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63097129 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.61788281 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61671519 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61642329 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61351401 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60532699 |
| 95 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60394087 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59433452 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58929981 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.58603498 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58201290 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58059791 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57870099 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.57858883 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57786391 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57672757 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57270718 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56539089 |
| 107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56070808 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56055677 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55526138 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55273006 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55014947 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54838048 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54505029 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52740995 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50049529 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49898024 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49050256 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48159476 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.47879408 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.47678226 |
| 121 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47166015 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46534417 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45762591 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.45475861 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45095538 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44028050 |
| 127 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43925526 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43093369 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42319635 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41859112 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41647775 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41045185 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40980900 |
| 134 | Prostate cancer_Homo sapiens_hsa05215 | 0.39613263 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38452768 |
| 136 | Salivary secretion_Homo sapiens_hsa04970 | 0.38150209 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.37784349 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36747541 |
| 139 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36423321 |
| 140 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36247586 |
| 141 | Focal adhesion_Homo sapiens_hsa04510 | 0.35538694 |
| 142 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34627032 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34471882 |
| 144 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34133490 |
| 145 | Legionellosis_Homo sapiens_hsa05134 | 0.33898946 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33100018 |

